New Insights in Amyloid Beta Interactions with Human Telomerase
The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
It is well-known that aging is the most risk factor for Alzheimer's disease (AD). Recent studies have demonstrated that human telomerase is associated with pathological mechanisms of AD. In view of the central role of telomere and telomerase in the aging process, herein we found that the aggregated form Aβ (Aβ1-40 and Aβ1-42), not Aβ monomer, could inhibit telomerase activity both in vitro and in living cells. The β-sheet structures were essential for Aβ-induced telomerase inhibition. Further studies indicated Aβ oligomers inhibited telomerase activity through binding to DNA·RNA hybrid formed by telomeric DNA and the RNA template of telomerase, then blocking telomerase elongation of telomeric DNA. We also identified that intracellular Aβ localized at telomere, and induced cell senescence and telomere shortening. These results indicate that Aβ oligomers can be potential natural inhibitors of telomerase and that inhibition of telomerase activity may be one of the factors for Aβ-induced cytotoxicity. Our work may offer a new clue to a better understanding of aging and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“β-amyloid can induce telomere shortening and inhibit telomerase activity167.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [167]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
[18] Quantification of β-sheet amyloid fibril structures with thioflavin T
LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111
Circular dichroic analysis of protein conformation: Inclusion of the β-turns
Chang, C. T., Wu, C.-S. C., & Yang, J. T. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90812-6 · Cited by 1,089
How Telomeres Solve the End-Protection Problem
de Lange, T. (2009) · Science · doi:10.1126/science.1170633 · Cited by 826
Structural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783
Structure–neurotoxicity relationships of amyloid β-protein oligomers
Ono, K., Condron, M. M., & Teplow, D. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905127106 · Cited by 770
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 751
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 635
Senescence and immortalization: Role of telomeres and telomerase
Shay, J. W., & Wright, W. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh296 · Cited by 610
A Simple, High-Resolution Method for Establishing DNA Binding Affinity and Sequence Selectivity
Boger, D. L., Fink, B. E., Brunette, S. R., Tse, W. C., & Hedrick, M. P. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010041a · Cited by 534
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
DNA minor-groove recognition by small molecules (up to 2000)
Neidle, S. (2001) · Natural Product Reports · doi:10.1039/a705982e · Cited by 494
Deshpande, A., Mina, E., Glabe, C., & Busciglio, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 494
Wheelhouse, R. T., Sun, D., Han, H., Han, F. X., & Hurley, L. H. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973792e · Cited by 448
Molecular Mechanisms of Amyloid Oligomers Toxicity
Kayed, R., & Lasagna-Reeves, C. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129001 · Cited by 415
Telomere shortening in T cells correlates with Alzheimer's disease status
Panossian, L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00043-x · Cited by 411
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
Riou, J. F., Guittat, L., Mailliet, P., Laoui, A., Renou, E., Petitgenet, O., Mégnin-Chanet, F., Hélène, C., & Mergny, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052698099 · Cited by 394
Preventing Alzheimer’s Disease
Selkoe, D. J. (2012) · Science · doi:10.1126/science.1228541 · Cited by 376
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka, E., Wheelhouse, R. T., Raymond, É., Davidson, K. K., Lawrence, R. A., Sun, D., Windle, B. E., Hurley, L. H., & Hoff, D. D. V. (1999) · PubMed · Cited by 366
Wirths, O., Multhaup, G., & Bayer, T. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02737.x · Cited by 350
Bartolini, M., Bertucci, C., Bolognesi, M. L., Cavalli, A., Melchiorre, C., & Andrisano, V. (2007) · ChemBioChem · doi:10.1002/cbic.200700427 · Cited by 348
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
Telomerase: An RNP Enzyme Synthesizes DNA
Blackburn, E. H., & Collins, K. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003558 · Cited by 335
The role of amyloid β peptide 42 in Alzheimer's disease
Findeis, M. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.006 · Cited by 324
Misonou, H., Morishima-Kawashima, M., & Ihara, Y. (2000) · Biochemistry · doi:10.1021/bi000169p · Cited by 304
Alzheimer's disease: a cell biological perspective
Kosik, K. (1992) · Science · doi:10.1126/science.1589757 · Cited by 283
Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease
Ohyagi, Y., Asahara, H., Chui, D.-H., Tsuruta, Y., Sakae, N., Miyoshi, K., Yamada, T., Kikuchi, H., Taniwaki, T., Murai, H., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2637fje · Cited by 281
Monchaud, D., Allain, C., Bertrand, H., Smargiasso, N., Rosu, F., Gabelica, V., De Cian, A., Mergny, J.-L., & Teulade-Fichou, M.-P. (2008) · Biochimie · doi:10.1016/j.biochi.2008.02.019 · Cited by 264
Anti-apoptotic Role of Telomerase in Pheochromocytoma Cells
Fu, W., Begley, J. G., Killen, M. W., & Mattson, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7264 · Cited by 248
Geng, J., Li, M., Ren, J., Wang, E., & Qu, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007067 · Cited by 238
Self-citationConformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
Ladiwala, A. R. A., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., Van Nostrand, W. E., & Tessier, P. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329763 · Cited by 225
Structural studies of soluble oligomers of the alzheimer β-amyloid peptide
Huang, T. H. J., Yang, D.-S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3559 · Cited by 212
Conformations and Biological Activities of Amyloid Beta Peptide 25-35
Millucci, L., Ghezzi, L., Bernardini, G., & Santucci, A. (2010) · Current Protein & Peptide Science · doi:10.2174/138920310790274626 · Cited by 195
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187
Fu, W., Killen, M., Culmsee, C., Dhar, S., Pandita, T. K., & Mattson, M. P. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:1-2:003 · Cited by 186
The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid β‐Peptide‐Induced Apoptosis
Zhu, H., Fu, W., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750117.x · Cited by 175
Visualizing Human Telomerase Activity with Primer‐Modified Au Nanoparticles
Wang, J., Wu, L. J., Ren, J., & Qu, X. (2011) · Small · doi:10.1002/smll.201101938 · Cited by 159
Self-citationMethyl green: A DNA major‐groove binding drug
Kim, S. K., & Nordén, B. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81133-k · Cited by 156
Kang, H. J., Choi, Y. S., Hong, S.-B., Kim, K.-W., Woo, R.-S., Won, S. J., Kim, E. J., Jeon, H. K., Jo, S.-Y., Kim, T. K., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4082-03.2004 · Cited by 138
Kinetic characterization of amyloid-beta 1–42 aggregation with a multimethodological approach
Bartolini, M., Naldi, M., Fiori, J., Valle, F., Biscarini, F., Nicolau, D. V., & Andrisano, V. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.03.020 · Cited by 134
Telomere Shortening and Alzheimer’s Disease
Cai, Z., Yan, L., & Ratka, A. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8207-9 · Cited by 128
Maloney, B., & Lahiri, D. K. (2011) · Gene · doi:10.1016/j.gene.2011.06.004 · Cited by 127
Li, X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl513 · Cited by 124
Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Aβ42 Peptide Relative to Aβ40
Kim, W., & Hecht, M. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505763200 · Cited by 123
Mattson, M. P. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00115-7 · Cited by 121
Naldi, M., Fiori, J., Pistolozzi, M., Drake, A. F., Bertucci, C., Wu, R., Młynarczyk, K., Filipek, S., Simone, A. D., & Andrisano, V. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000982 · Cited by 119
Intraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic models
Wirths, O., & Bayer, T. A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.001 · Cited by 106
Donnini, S., Solito, R., Cetti, E., Corti, F., Giachetti, A., Carra, S., Beltrame, M., Cotelli, F., & Ziche, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-146456 · Cited by 86
Franco, S., Blasco, M. A., Siedlak, S. L., Harris, P. L. R., Moreira, P. I., Perry, G. L., & Smith, M. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.03.001 · Cited by 82
Bailey, J. A., Maloney, B., Ge, Y.-W., & Lahiri, D. K. (2011) · Gene · doi:10.1016/j.gene.2011.06.017 · Cited by 79
Hegde, M. L., Anitha, S., Latha, K. S., Mustak, M. S., Stein, R., Ravid, R., & Rao, K. S. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:1-2:19 · Cited by 77
Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
Shie, F.-S., LeBoeur, R. C., & Jin, L.-W. (2003) · NeuroReport · doi:10.1097/00001756-200301200-00023 · Cited by 70
B�ckig, A., Tikkanen, R., Herzog, V., & Schmitz, A. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-002-0459-2 · Cited by 67
Zhao, C., Ren, J., Gregoliński, J., Lisowski, J., & Qu, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks524 · Cited by 62
Self-citationTime-Dependent DNA Condensation Induced by Amyloid β-Peptide
Yu, H., Ren, J., & Qu, X. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.093559 · Cited by 60
Self-citationAlzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form
Geng, J., Zhao, C., Ren, J., & Qu, X. (2010) · Chemical Communications · doi:10.1039/c0cc02049d · Cited by 55
Self-citationTuite, E., Sehlstedt, U., Hagmar, P., Nordén, B., & Takahashi, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0482a.x · Cited by 44
Intraneuronal amyloid β42 enhanced by heating but counteracted by formic acid
Ohyagi, Y., Tsuruta, Y., Motomura, K., Miyoshi, K., Kikuchi, H., Iwaki, T., Taniwaki, T., & Kira, J. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.06.010 · Cited by 39
Interaction between Alzheimer's Aβ1-42 Peptide and DNA Detected by Surface Plasmon Resonance
Barrantes, A., Rejas, M. T., Benítez, M. J., & Jiménez, J. S. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12408 · Cited by 34
Li, J., Tang, B., Qu, Y., & Mu, D. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.07.010 · Cited by 30
Nuclear and Cytoplasmic Localization of the β-Amyloid Peptide (1–43) in Transfected 293 Cells
Johnstone, E. M., Babbey, L. E., Stephenson, D. T., Paul, D. C., Santerre, R. F., Clemens, J. A., Williams, D. C., & Little, S. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0469 · Cited by 26
Chiu, W., Shen, S., Yang, L., Chow, J., Wu, C.-Y., & Chen, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22536 · Cited by 24
Specific binding of DNA to aggregated forms of Alzheimer's disease amyloid peptides
Camero, S., Ayuso, J. M., Barrantes, A., Benítez, M. J., & Jiménez, J. S. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.01.007 · Cited by 23
Structural, kinetic and cytotoxicity aspects of 12–28 β‐amyloid protein fragment: a reappraisal
Rabanal, F., Tusell, J. M., Sastre, L., Quintero, M., Cruz, M., Grillo‐Bosch, D., Pons, M., Alberício, F., Serratosa, J., & Giralt, E. (2002) · Journal of Peptide Science · doi:10.1002/psc.418 · Cited by 23
Research works printed but not linked: 3
- Kosik K. S., 1992, Science, 256, 780, 10.1126/science.256.5058.780 · doi:10.1126/science.256.5058.780 · Paper page
- Ohyagi Y., 2004, FASEB J., 19, 255
- Izbicka E., 1999, Cancer Res., 59, 639
Cited by
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Fu, W., Yan, C., Guo, Z., Zhang, J., Zhang, H., Tian, H., & Zhu, W.-H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b12820 · Cited by 444
Rajasekhar, K., Chakrabarti, M., & Govindaraju, T. (2015) · Chemical Communications · doi:10.1039/c5cc05264e · Cited by 241
The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S., & Stellos, K. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.033 · Cited by 188
“Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.”
BackgroundInfluentialThe size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation
Gao, G., Zhang, M., Gong, D., Chen, R., Hu, X., & Sun, T. (2017) · Nanoscale · doi:10.1039/c7nr00699c · Cited by 164
Metadata
- Authors
- Wang, J., Zhao, C., Zhao, A., Li, M., Ren, J., & Qu, X.
- Affiliations
- Changchun Institute of Applied Chemistry (CN)
- Corresponding author
- Qu, Xiaogang
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-01-17
- Volume
- 137
- Issue
- 3
- Pages
- 1213-1219
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2319211999
- Cited by
- 90
- References
- 82
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 14 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 10 · 2017: 9 · 2016: 6 · 2015: 3
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Chemical Society (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2011CB936004, 2012CB720602)
- National Natural Science Foundation of China (21210002, 91213302)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- amyloid-beta, human telomerase, telomerase inhibition, amyloid-beta oligomers, beta-sheet, telomeric DNA, telomere shortening, cellular senescence, Alzheimer's disease, aging
- MeSH terms
- Animals, Cell Survival, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Humans, Structure-Activity Relationship, Amyloid beta-Peptides, PC12 Cells, Telomerase, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.